Epilepsy Foundation Chair Warren Lammert spoke to KCNC CBS-4 in Denver this week about the Epilepsy Foundation's stance on medical marijuana, the use of CBD oil as a treatment, and his daughter Sylvie's epilepsy. Click the video below to view the report.
This news report shows why the Epilepsy Foundation supports the rights of patients and families living with seizures and epilepsy to access physician directed care, including medical marijuana. Nothing should stand in the way of patients gaining access to potentially life-saving treatment, especially not their zip code.
A lack of medical marijuana research is a major concern for public health and patient safety, consistent dosage, and potential side effects. However, the hope provided for some is highly sought by families, like the Lammerts, in need. Unfortunately, because marijuana-based products including the non-psychoactive cannabidiol are Schedule I drugs, it is very difficult for researchers to perform needed studies. Because of this, we created a petition urging the Obama administration to ask the Drug Enforcement Agency to reschedule marijuana products so researchers can study the benefits and side effects of this treatment option that could potentially help millions of people living with epilepsy. To sign the epilepsy petition please visit petitions.whitehouse.gov.